DPL XXXVII Conference Website 

The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a non-profit which encourages diversity & inclusion with the Society, regardless of differing backgrounds, perspectives, experiences, orientations, origins, and practice settings. The Society embraces participation and diversity as it leads to advancing our purpose: 

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

Latest News

FDA Advisory Committee Nominates Six Peptides for Pharmacies to Compound

The Food and Drug Administration’s Pharmacy Compounding Advisory Committee (PCAC) voted to recommend that the FDA include peptides BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax on the 503A Bulks List, which outlines the bulk drug substances that compounding pharmacies can use in creating medications. The committee also rejected adding emideltide to the list.

PCAC’s votes are recommendations and are not binding on the FDA. Secretary of Health and Human Services Robert F. Kennedy, Jr. will still need to formally approve the substances’ addition to the 503A Bulks List. Pharmacies will not be permitted to compound them until the final rulemaking is in place, even if companies release pharmaceutical-grade active pharmaceutical ingredients. Kennedy has expressed support for compounding peptides.

For details on the meeting, including links to the full video recordings, click here.